Lundbeck in Japan

Below is a brief history of Lundbeck activities in Japan

Lundbeck logo
2011 Otsuka Pharmaceutical Co., Ltd. and Lundbeck signs worldwide agreement to deliver innovative medicines with focus on psychiatric disorders

2011 Lundbeck Japan celebrates 10th Anniversary in Japan 

2011 Lundbecks partner Mochida Pharmaceutical Co., Ltd. receives marketing authorisation of Lexapro® (escitalopram) and launches the product in Japan

2010 Lundbeck partner Mochida Pharmaceutical Co., Ltd. submits J-NDA for Lexapro®

2010 Lundbeck Japan initiates first own Clinical Study in Japan

2007 Lundbeck signs agreement with Takeda Pharmaceutical Company Limited to co-develop and co-commercialize a new generation of antidepressants including Japanese market

2001 Lundbeck signs agreement with Mochida Pharmaceutical Co., Ltd. to develop and commercialise Lexapro® escitalopram in Japan

2001 Lundbeck Japan K.K. is established

Lundbeck Culture


Learn more about Lundbeck Culture.

Read more

Contact Us

2 people talking

Contact us if you are interested in knowing more about our company.

Read more
You are about to leave